(NTLA) Intellia Therapeutics Renko charts technical analysis
(NTLA) Intellia Therapeutics Renko charts technical analysis Renko analysis of Intellia Therapeutics | Buy/Sell Intellia Therapeutics
Intellia Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Intellia Therapeutics is 5815141
| Date | Closing Price | Open | High | Low | Volume |
| 23 Thu Oct 2025 | 25.88 | 25.00 | 25.95 | 24.27 | 1.982 Mn |
| 22 Wed Oct 2025 | 24.56 | 27.20 | 27.72 | 24.14 | 4.51 Mn |
| 21 Tue Oct 2025 | 26.97 | 27.60 | 27.86 | 26.70 | 5.14 Mn |
| 20 Mon Oct 2025 | 27.98 | 25.34 | 28.25 | 25.13 | 5.428 Mn |
| 17 Fri Oct 2025 | 25.00 | 23.20 | 25.18 | 22.01 | 3.071 Mn |
| 16 Thu Oct 2025 | 24.85 | 26.12 | 26.82 | 24.61 | 3.985 Mn |
| 15 Wed Oct 2025 | 25.93 | 24.48 | 26.32 | 24.23 | 5.518 Mn |
| 14 Tue Oct 2025 | 23.90 | 23.10 | 24.83 | 21.89 | 4.958 Mn |
| 13 Mon Oct 2025 | 23.76 | 24.88 | 25.81 | 23.42 | 6.972 Mn |
| 10 Fri Oct 2025 | 24.52 | 25.62 | 25.78 | 23.22 | 8.649 Mn |
Indicators analysis of Intellia Therapeutics (NTLA)
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Intellia Therapeutics in short term but the sell signal is initial and weak.
Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Intellia Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 25.25 and Intellia Therapeutics (NTLA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Renko charts
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Intellia Therapeutics in short term but the sell signal is initial and weak.
Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Intellia Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 25.25 and Intellia Therapeutics (NTLA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.